Clinical Trial Update: Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 randomized study evaluating a combined herbal formulation (artichoke, milk thistle, turmeric, and licorice) for imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic-associated Fatty Liver Disease

Drugs mentioned

• Artichoke (Cynara scolymus) (Cynara scolymus)
• Licorice (Glycyrrhiza glabra) (Glycyrrhiza glabra)
• Milk thistle (Silybum marianum) (Silybum marianum)
• Turmeric (Curcuma longa) (Curcuma longa)

Snippet

Sponsor: Li Lab,MD | Conditions: Metabolic-associated Fatty Liver Disease (MAFLD) | Phase 2 | Status: RECRUITING